The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?

When oral dopaminergic medication falls short in the treatment of Parkinson’s disease, patients are left with motor response fluctuations and dyskinesias that may have a large impact on functioning in daily life. They may benefit from one of the currently available advanced treatments, namely deep b...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijk, Joke M., Espay, Alberto J., Katzenschlager, Regina, de Bie, Rob M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592668/
https://www.ncbi.nlm.nih.gov/pubmed/32651333
http://dx.doi.org/10.3233/JPD-202104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592668/
https://www.ncbi.nlm.nih.gov/pubmed/32651333
http://dx.doi.org/10.3233/JPD-202104

Ejemplares similares